Search research articles
Contact Us
Filters
Showing results (581-590 of 608) with videos related to
Page
of 61
Sort By:
European Heart Journal. Acute Cardiovascular Care
|
June 9, 2023
Impact of annual volume of cases and intensive cardiac care unit availability on mortality of patients with acute myocardial infarction-related cardiogenic shock treated at revascularization capable centres
M Isabel Barrionuevo-Sánchez, Ana Viana-Tejedor, Albert Ariza-Solé, et al.
Journal of the American College of Cardiology
|
November 9, 2024
Effect of Finerenone on the KCCQ in Patients With HFmrEF/HFpEF: A Prespecified Analysis of FINEARTS-HF
Mingming Yang, Alasdair D Henderson, Atefeh Talebi, et al.
Journal of Personalized Medicine
|
August 25, 2023
Soluble Transferrin Receptor as Iron Deficiency Biomarker: Impact on Exercise Capacity in Heart Failure Patients
Maria Del Mar Ras-Jiménez, Raúl Ramos-Polo, Josep Francesch Manzano, et al.
Nature Medicine
|
December 15, 2022
Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial
Orly Vardeny, James C Fang, Akshay S Desai, et al.
International Journal of Cardiology
|
May 1, 2014
Repetitive use of levosimendan for treatment of chronic advanced heart failure: clinical evidence, practical considerations, and perspectives: an expert panel consensus
M S Nieminen, J Altenberger, T Ben-Gal, et al.
European Journal of Heart Failure
|
September 29, 2023
Impact of COVID-19 in patients with heart failure with mildly reduced or preserved ejection fraction enrolled in the DELIVER trial
Ankeet S Bhatt, Mikhail N Kosiborod, Brian L Claggett, et al.
International Journal of Cardiology
|
May 19, 2015
The patient perspective: Quality of life in advanced heart failure with frequent hospitalisations
Markku S Nieminen, Kenneth Dickstein, Cândida Fonseca, et al.
Nature Medicine
|
March 1, 2022
The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial
Adriaan A Voors, Christiane E Angermann, John R Teerlink, et al.
Medicina Intensiva
|
July 18, 2015
Forum for debate: Safety of allogeneic blood transfusion alternatives in the surgical/critically ill patient
M Muñoz Gómez, E Bisbe Vives, M Basora Macaya, et al.
The Lancet. Digital Health
|
May 15, 2025
Evaluation of mobile health technology combining telemonitoring and teleintervention versus usual care in vulnerable-phase heart failure management (HERMeS): a multicentre, randomised controlled trial
Sergi Yun, Josep Comín-Colet, Esther Calero-Molina, et al.
Page
of 61
Search research articles
Search
Showing results (581-590 of 608) with videos related to
Sort By:
Page
of 61
European Heart Journal. Acute Cardiovascular Care
|
June 9, 2023
Impact of annual volume of cases and intensive cardiac care unit availability on mortality of patients with acute myocardial infarction-related cardiogenic shock treated at revascularization capable centres
M Isabel Barrionuevo-Sánchez, Ana Viana-Tejedor, Albert Ariza-Solé, et al.
Journal of the American College of Cardiology
|
November 9, 2024
Effect of Finerenone on the KCCQ in Patients With HFmrEF/HFpEF: A Prespecified Analysis of FINEARTS-HF
Mingming Yang, Alasdair D Henderson, Atefeh Talebi, et al.
Journal of Personalized Medicine
|
August 25, 2023
Soluble Transferrin Receptor as Iron Deficiency Biomarker: Impact on Exercise Capacity in Heart Failure Patients
Maria Del Mar Ras-Jiménez, Raúl Ramos-Polo, Josep Francesch Manzano, et al.
Nature Medicine
|
December 15, 2022
Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial
Orly Vardeny, James C Fang, Akshay S Desai, et al.
International Journal of Cardiology
|
May 1, 2014
Repetitive use of levosimendan for treatment of chronic advanced heart failure: clinical evidence, practical considerations, and perspectives: an expert panel consensus
M S Nieminen, J Altenberger, T Ben-Gal, et al.
European Journal of Heart Failure
|
September 29, 2023
Impact of COVID-19 in patients with heart failure with mildly reduced or preserved ejection fraction enrolled in the DELIVER trial
Ankeet S Bhatt, Mikhail N Kosiborod, Brian L Claggett, et al.
International Journal of Cardiology
|
May 19, 2015
The patient perspective: Quality of life in advanced heart failure with frequent hospitalisations
Markku S Nieminen, Kenneth Dickstein, Cândida Fonseca, et al.
Nature Medicine
|
March 1, 2022
The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial
Adriaan A Voors, Christiane E Angermann, John R Teerlink, et al.
Medicina Intensiva
|
July 18, 2015
Forum for debate: Safety of allogeneic blood transfusion alternatives in the surgical/critically ill patient
M Muñoz Gómez, E Bisbe Vives, M Basora Macaya, et al.
The Lancet. Digital Health
|
May 15, 2025
Evaluation of mobile health technology combining telemonitoring and teleintervention versus usual care in vulnerable-phase heart failure management (HERMeS): a multicentre, randomised controlled trial
Sergi Yun, Josep Comín-Colet, Esther Calero-Molina, et al.
Page
of 61